{"nct_id":"NCT06121843","title":"A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2024-02-22","start_date_type":"ACTUAL","primary_completion_date":"2028-08-01","primary_completion_date_type":"ESTIMATED","completion_date":"2028-08-01","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["BMY"]}